Authors: Scott, DL Smolen, JS Kalden, JR van de Putte, LBA Larsen, A Kvien, TK Schattenkirchner, M Nash, P Oed, C Loew-Friedrich, I

Citation: Dl. Scott et al., Treatment of active rheumatoid arthritis with leflunomide: two year followup of a double blind, placebo controlled trial versus sulfasalazine, ANN RHEUM D, 60(10), 2001, pp. 913-923

Authors: Emery, P Breedveld, FC Lemmel, EM Kaltwasser, JP Dawes, PT Gomor, B Van den Bosch, F Nordstrom, D Bjorneboe, O Dahl, R Horslev-Petersen, K de la Serna, AR Molloy, M Tikly, M Oed, C Rosenburg, R Loew-Friedrich, I

Citation: P. Emery et al., A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis, RHEUMATOLOG, 39(6), 2000, pp. 655-665

Authors: Schiff, MH Strand, V Oed, C Loew-Friedrich, I

Citation: Mh. Schiff et al., Leflunomide: Efficacy and safety in clinical trials for the treatment of rheumatoid arthritis, DRUGS TODAY, 36(6), 2000, pp. 383-394

Authors: Sharp, JT Strand, V Leung, H Hurley, F Loew-Friedrich, I

Citation: Jt. Sharp et al., Treatment with leflunomide slows radiographic progression of rheumatoid arthritis - Results from three randomized controlled trials of leflunomide inpatients with active rheumatoid arthritis, ARTH RHEUM, 43(3), 2000, pp. 495-505

Authors: Smolen, JS Kalden, JR Scott, DL Rozman, B Kvien, TK Larsen, A Loew-Friedrich, I Oed, C Rosenburg, R

Citation: Js. Smolen et al., Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial, LANCET, 353(9149), 1999, pp. 259-266

Authors: Strand, V Cohen, S Schiff, M Weaver, A Fleischmann, R Cannon, G Fox, R Moreland, L Olsen, N Furst, D Caldwell, J Kaine, J Sharp, J Hurley, F Loew-Friedrich, I

Citation: V. Strand et al., Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate, ARCH IN MED, 159(21), 1999, pp. 2542-2550